Libtayo 350 MG/7 ML vial 7ML
Ended Awarded
- Contract number
- SPE2DB25FP9A0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $65,177
Award facts
- Contract value 100% obligated
- $65,177.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $65,177.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of LIBTAYO (cemiplimab) 350 mg/7 mL vials. The contract, awarded on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a non-set-aside competitive award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, leverages its comprehensive portfolio of pharmaceutical capabilities to fulfill this oncology medication requirement for the Department of Defense healthcare systems. The company's selection through open competition demonstrates its capacity to meet federal procurement standards for specialty pharmaceuticals. LIBTAYO, an immune checkpoint inhibitor used in cancer treatment, represents the type of specialized medical commodity that AmerisourceBergen delivers through its extensive federal contract awards with the Defense Logistics Agency, supporting the military and veteran healthcare systems' pharmaceutical supply chain requirements.
Quick answers
Who was awarded contract SPE2DB25FP9A0?
SPE2DB25FP9A0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FP9A0 worth?
The government has obligated $65,177 on SPE2DB25FP9A0.
Is contract SPE2DB25FP9A0 an order under another contract?
Yes. SPE2DB25FP9A0 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP9A0 competed?
The extent of competition for SPE2DB25FP9A0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award